Author:
Saha V.,Jacob John T.,Mukundan P.,Gnanamuthu C.,Prabhakar S.,Arjundas G.,Sayeed Z. A.,Kumaresan G.,Srinivas K.
Abstract
SUMMARYDuring 19837 a clinical diagnosis of subacute sclerosing panencephalitis (SSPE) was confirmed by the detection of measles virus haemagglutination inhibiting antibody in the cerebrospinal fluid (CSF) in 81 subjects resident in Tamilnadu. The antibody titre (reciprocol of the endpoint dilution) in the CSF ranged from 2 to 32 and in the sera from 8 to 2048. The CSF: serum ratios of titres were 1:41:64 in 80 cases and 1:128 in one case. The median age at onset of SSPE was 10 years and 97% of cases were diagnosed at stage 2 and beyond. Based on the geographic distribution of 72 cases in an estimated population of 84 million, the annual incidence of SSPE was calculated to be 214 per million population, or 43 cases per million children below 20 years. Assuming that only 10% of all cases would have reached the level of laboratory diagnosis, the incidence may be as high as 21 cases per million population.
Publisher
Cambridge University Press (CUP)
Subject
Infectious Diseases,Epidemiology
Reference20 articles.
1. SUBACUTE SCLEROSING PANENCEPHALITIS IN THE MIDDLE EAST
2. 13. Padmanabha P. Census of India 1981 part-II special: Report and tables based on 5% sample data. Office of the Registrar General of India, New Delhi; 1983.
3. Subacute Sclerosing Panencephalitis
4. Subacute sclerosing panencephalitis.
5. The changing clinical expression of SSPE in the USA;Dyken;Ann Neurol,1982
Cited by
64 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献